Alimera Sciences
ALIM
ALIM was delisted on the 13th of September, 2024.
54 hedge funds and large institutions have $56.2M invested in Alimera Sciences in 2016 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 12 closing their positions.
66% more capital invested
Capital invested by funds: $33.8M → $56.2M (+$22.4M)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
42% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 12
10% more funds holding
Funds holding: 49 → 54 (+5)
8% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$5.49M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$4.05M |
| 3 |
AC
Armistice Capital
New York
|
+$3.79M |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$2.93M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.54M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JGC
J. Goldman & Co
New York
|
-$2.2M |
| 2 |
Goldman Sachs
New York
|
-$1M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$148K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$140K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$135K |
ALIM Hedge Fund Activity: Q3 2016 in Review
54 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q3 2016, worth a combined $56.2M — up 66% from $33.8M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new ALIM positions and 12 closed out — a net gain of 5 holders — while 11 added to existing stakes and 12 trimmed.
The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $5.49M. The largest seller was J. Goldman & Co, cutting an estimated $2.2M.
- 54 institutional investors held Alimera Sciences (ALIM) as of Q3 2016, up from 49 in Q2 2016.
- Funds reported $56.2M of Alimera Sciences stock for Q3 2016, up 66% quarter-over-quarter.
- 17 funds opened new Alimera Sciences positions in Q3 2016 and 12 closed out, a net change of +5 holders.
- The largest Alimera Sciences buyer in Q3 2016 was Avoro Capital Advisors, an estimated $5.49M added.
- The largest Alimera Sciences seller in Q3 2016 was J. Goldman & Co, an estimated $2.2M sold.
Based on aggregated 13F filings for Q3 2016.